Effect of aflatoxin B1 on DNA structural characteristic by Al-Terehi, Mona Najah
 
Research in Pharmacy 2(2) : 35-38, 2012                                                ISSN : 2231-539X 
www.researchinpharmacy.com 
 
 
 
Short communication 
Effect of aflatoxin B1 on DNA structural characteristic 
 
Mona Najah Al-Terehi 
 
  Department of Biology, College of Science, Kufa University 
 
The present investigation is an attempt to detection the effect of aflatoxin B1 on 
structural characteristic of DNA in different tissue, include liver, kidney, spleen and 
blood, in vivo by treated weight albino rate to AFB1 for 2 weeks as oral daily dose 1 ml/ 
kg. DNA fragmentation test was used to detect changes in DNA and micronuclei test in 
bone marrow cell.  the results show that AFB1 causes lyses in DNA in all tissue and 
blood in variant level compare with negative control, liver show greater level than other 
organs 9660 pb, spleen was 9133 pb, kidney was 6166 pb and lower level in blood was 
1366 pb. So it cause increased in micronuclei formation in bone marrow cell. 
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  Aflatoxines are one of mycotoxin that product by fungi like Asperagillus spp. 
Aflatoxine B1 (AB1) is one of among potent genotoxic agent (8) it causes chromosomal 
aberration and DNA breakage in plant and animal cell and induced lethal mutation in mice 
and significant decrease in the fertility by genetic damage or mutation in germ cell  (3,18) 
other researchers reported that the large dose of aflatoxin may be lethal but sub lethal cases 
chronic toxicity and low chronic dose causes neoplasma, liver cancer, inhibit DNA 
synthesis, RNA synthesis, and proteine synthesis (4,11). So AF causes hepatocarcinogeneses 
in human and mutation in p53 tumor suppression gene (1). Furthermore studies in rat, mice, 
and fish improved the aflatoxin activation protooncogenes and transversion mutation G→A 
and G→T in codon 12 in Ki-ras gene (10).  
 
Materials and methods 
• Aflatoxin: aflatoxin extraction from Asperagillus terreus according to (7), detection AFB1 
by thin layer chromatography (TLC) by use methanol: chloroform (97: 3) (v/v) (16). 
• Experimental design: using female rats (250±50 g body weight, age 14±2 weaks) animals 
divided in to 2 groups for DNA studying, first treatment by tap water as negative control, 
second treatment by aflatoxine B1 in daily dose 1ml/kg for 15 days. For micronuclei 
animal divided in to 3 grouped, first treatment by tap water as negative control , second 
treatment by aflatoxine B1 in daily dose 1ml/kg for 15 days, third treated by 
cyclophosphomide  drug as positive control in 10 mg\kg for 15 day .     
• DNA assay :  using DNA  fragmentation test , DNA  extraction  from liver , kidney, 
spleen and whole blood  by Genomic DNA purification kit (Promega USA ) . The purity 
and concentration according to (13) then electrophoresis of DNA according to (12) with 
some modification.  
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• Micronuclei assay: Micronuclei assay was performed according to (9)  with some 
modification , slide colored by Giemza stain then exam in microscope  (Meiji, Japan) to 
detection micronuclei in 1000 cell.  
 
Results and Discussion 
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Figure (1)  Electrophoresis of  DNA extraction from different tissues of animal treated by 
aflatoxine B1. Lane 1, 2, 3 DNA extract from liver. Lane 4, 5, 6 DNA extract from kidney. 
Lane 7, 8, 9 DNA extract from spleen. Lane 10, 11, 12 DNA extract from blood. Lane 13 
DNA marker. Lane 14 DNA extract from negative control. 
 
Table (1) DNA lyses level of different tissues explained in figure (1) 
Lane 
number 
Approximately 
Molecular size of  
DNA (bp) 
Lyses level Tissue type Average of 
lyses level bp 
1 1000 9000 liver ≈ 9660 
2 < 300 ≈ 9700 liver 
3 < 300 ≈ 9700 liver 
4 500 9500 kidney ≈ 6166 
5 < 5000 ≈ 5000 kidney 
6 < 6000 ≈ 4000 kidney 
7 300 9700 spleen ≈ 9133 
8 2000 8000 spleen 
9 < 300 ≈ 9700 Spleen 
10 6000 4000 Blood ≈ 1366 
11 10000 No lyses Blood 
12 ≈ 10000 < 100 Blood 
13 DNA marker No lyses  _ 
14 > 10000 No lyses Negative control _ 
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Table 2.  Macronuclei value in bone marrow cells. 
 
 
 
 
 
 
 
 
 
 M±Se             * significant (p<0.05) 
 
The result show that aflatoxine B1 cusses DNA damage in liver , kidney ,  spleen and 
blood in different level show in figure (1) , the reason of this damage because AFB1- DNA 
adduct that form 8,9-epoxide and 8,9 – dihydro-8-( N7-guanyl)-9-hydroxy- AFB1 by covalent 
bond between C8 of AFB1 – 8,9-epoxides and N7 of G base in DNA, or by pre covalent 
intercalation complex between double strand DNA and highly electrophelic unstable AFB1 
– exo -8,9 peroxide isomers  (15) . in the other hand oxidative stress caused by rats exposure 
to AFB1 can induced DNA lyses by forming (8-oxo dG) in liver DNA (14) .  The level of 
DNA lyses have been showed in table (1). Liver was affected more than other tissue, the 
lyses level was 9660 pb, other researchers improved  that rats exposed to single dose of 
AFB1 showed 10- folded greater level of DNA adduct in liver than in kidney , similar  result 
have been reported in fish (6) ,  so the  metabolic activation of AF by cytochrome CYP1A2 in 
liver it was more sensitive to toxic and mutagenic effect of AFB1 (5), kidney showed lower 
level of  DNA  lyses  than liver and spleen, it had 6166 pb Bailey et al. (1988) reported that 
DNA adduct in kidney was low level than other organs in rainbow trout and salmon (2)  
blood DNA showed lower lyses level it was 1366 pb, the lower level of blood  than other 
organs and tissue because blood cleaned by kidney and detoxificated by liver . micronuclei 
was increased in bone marrow cell of rats this may because of genotoxity of AFB1 it most 
potent genotoxic agent, is mutagenic in many model systems and produces chromosomal 
aberrations, micronuclei, sister-chromatid exchange, unscheduled DNA synthesis, and 
chromosomal strand breaks as well as forms adducts in rodent and human cells (17) .  
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